- Home
- Publications
- Publication Search
- Publication Details
Title
Blocking CGRP in migraine patients – a review of pros and cons
Authors
Keywords
Migraine, Cgrp, Cgrp receptor, Prophylactic treatment, Acute treatment, Gepants
Journal
JOURNAL OF HEADACHE AND PAIN
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-09-25
DOI
10.1186/s10194-017-0807-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Calcitonin gene-related peptide and pain: a systematic review
- (2017) Wendy Sophie Schou et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine
- (2017) Smriti Iyengar et al. PAIN
- Ictal lack of binding to brain parenchyma suggests integrity of the blood–brain barrier for11C-dihydroergotamine during glyceryl trinitrate-induced migraine
- (2016) Christoph J. Schankin et al. BRAIN
- A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
- (2016) Tiffini Voss et al. CEPHALALGIA
- Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Hong Sun et al. LANCET NEUROLOGY
- Wiping Out CGRP: Potential Cardiovascular Risks
- (2016) Antoinette MaassenVanDenBrink et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Migraine and risk of cardiovascular disease in women: prospective cohort study
- (2016) Tobias Kurth et al. BMJ-British Medical Journal
- Migraine and risk of cardiovascular disease in women: prospective cohort study
- (2016) Tobias Kurth et al. BMJ-British Medical Journal
- Comment on “A second trigeminal CGRP receptor: function and expression of the AMY1 receptor”
- (2016) Kristian Agmund Haanes et al. Annals of Clinical and Translational Neurology
- Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood–brain barrier
- (2015) Sajedeh Eftekhari et al. BRAIN RESEARCH
- Therapeutic antibodies against CGRP or its receptor
- (2015) Marcelo E. Bigal et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment
- (2015) Lars Edvinsson BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine
- (2015) Tony W Ho et al. CEPHALALGIA
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Adherence to oral migraine-preventive medications among patients with chronic migraine
- (2014) Zsolt Hepp et al. CEPHALALGIA
- CGRP antagonists and antibodies for the treatment of migraine
- (2014) László Vécsei et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
- (2014) T. W. Ho et al. NEUROLOGY
- Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain
- (2014) R.J. Benschop et al. OSTEOARTHRITIS AND CARTILAGE
- Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
- (2014) F. A. Russell et al. PHYSIOLOGICAL REVIEWS
- Migraine and the Risk for Stroke and Cardiovascular Disease
- (2014) Simona Sacco et al. Current Cardiology Reports
- BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
- (2013) Ronald Marcus et al. CEPHALALGIA
- Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development
- (2013) Marcelo E. Bigal et al. HEADACHE
- Epidermal Nerve Fibers Modulate Keratinocyte Growth via Neuropeptide Signaling in an Innervated Skin Model
- (2013) Dennis Roggenkamp et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
- (2013) Sajedeh Eftekhari et al. JOURNAL OF PAIN
- Preventive treatment in migraine and the new US guidelines
- (2013) Emad Estemalik et al. Neuropsychiatric Disease and Treatment
- Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease
- (2012) Tony W. Ho et al. HEADACHE
- Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1
- (2012) S.D. Silberstein et al. NEUROLOGY
- Mechanisms of Monoclonal Antibody–Drug Interactions
- (2011) Honghui Zhou et al. Annual Review of Pharmacology and Toxicology
- Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
- (2011) David J Hewitt et al. CEPHALALGIA
- Randomized Controlled Study of Telcagepant Plus Ibuprofen or Acetaminophen in Migraine
- (2011) David J. Hewitt et al. HEADACHE
- Prophylaxis of migraine: general principles and patient acceptance
- (2011) Domenico D'Amico et al. Neuropsychiatric Disease and Treatment
- Calcitonin gene-related peptide facilitates revascularization during hindlimb ischemia in mice
- (2010) Toshiaki Mishima et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Inhibitory Effects of Calcitonin Gene-Related Peptides on Experimental Vein Graft Disease
- (2010) Xiaoning Zhang et al. ANNALS OF THORACIC SURGERY
- BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
- (2010) Hans-Christoph Diener et al. CEPHALALGIA
- Randomized, controlled trial of telcagepant over four migraine attacks
- (2010) Andrew P Ho et al. CEPHALALGIA
- Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial
- (2010) Kathryn M. Connor et al. HEADACHE
- New drugs in migraine treatment and prophylaxis: telcagepant and topiramate
- (2010) Lars Edvinsson et al. LANCET
- Possible sites of action of the new calcitonin gene-related peptide receptor antagonists
- (2010) Sajedeh Eftekhari et al. Therapeutic Advances in Neurological Disorders
- Randomized, controlled trial of telcagepant for the acute treatment of migraine
- (2009) K. M. Connor et al. NEUROLOGY
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
- (2008) Tony W Ho et al. LANCET
- Inhibitory effect of BIBN4096BS, CGRP8-37, a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery
- (2007) L Edvinsson et al. BRITISH JOURNAL OF PHARMACOLOGY
- Roles of Calcitonin Gene–Related Peptide in Maintenance of Gastric Mucosal Integrity and in Enhancement of Ulcer Healing and Angiogenesis
- (2007) Takashi Ohno et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now